Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

A serum creatinine measurement should be obtained within 10 days before the first infusion of zoledronic acid. Serum creatinine measurements should be obtained before each subsequent dose of ...

Ketorolac is a non-steroidal anti-inflammatory agent (NSAID), prescribed for short-term management of severe pain, usually after surgery that requires analgesia (pain killer) at the opioid level ...

Zoledronic acid is used to treat high levels of a mineral called calcium in people who have cancer. It is also used to treat or prevent weakening of the bones (osteoporosis) caused by menopause or ...

gastroesophageal reflux disease (GERD), erosive esophagitis (inflammation of esophagus), and Zollinger-Ellison (gastric acid hyper secretion) syndrome. Lansoprazole can cause an increase in the ...

Interactions between symbiotic or pathogenic microbes and the hosts they colonize are central to both health and disease. This rapidly advancing field is now bearing the fruits of ...

When that happens, it's called a drug interaction. It could make your medication stop working, become less effective, or too strong. It could also trigger side effects. The more you learn about ...

We work to elucidate the molecular mechanisms involved in tumour cell-bone cell interactions, and how these can be targeted by anti-cancer therapies, including CDK4/6 inhibitors. We also investigate ...

Human-Computer Interaction (HCI) is a rapidly expanding area of research and development that has transformed the way we use computers in the last thirty years. Research topics and areas include ...

They’re generally safe and effective, but side effects are always possible. Bisphosphonates may interact with other drugs not listed in this article, so make sure you discuss any medications you ...

Being able to predict and tailor the way cells and tissues interact with biomaterials is critical to the development of novel materials for use in human implants. Going beyond simple cytotoxicity ...